more meaningful moments
For people living with blood cancer, progress is more than clinical outcomes. It’s about having more energy, fewer limitations, and more moments that matter. Driven by urgency and guided by purpose, we’re working to make those moments possible.
beyond the diagnosis
The unseen challenges of blood cancers
Blood cancer affects more than blood counts. Symptoms, treatment demands, and uncertainty shape everyday life and reinforce the need for innovative treatment options.
Unlocking the potential of telomerase inhibition
Our scientific foundation is built on decades of research into telomerase, an enzyme that plays a key role in how many cancers survive and multiply.
Telomerase had long been recognized as a compelling target in cancer biology but translating that science into a meaningful therapy proved challenging. Geron helped change that by bringing the first clinically validated telomerase inhibitor to patients with LR-MDS.
What’s New
View our latest news and events
Because patients cannot wait
Driven by urgency and guided by purpose, we’re committed to pursuing new possibilities for people living with blood cancer.